These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 14712483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [Abstract] [Full Text] [Related]

  • 3. Effects of tumor necrosis factor alpha in renal cell carcinoma.
    Ikemoto S, Narita K, Yoshida N, Wada S, Kishimoto T, Sugimura K, Nakatani T.
    Oncol Rep; 2003; 10(6):1947-55. PubMed ID: 14534724
    [Abstract] [Full Text] [Related]

  • 4. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 5. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M.
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [Abstract] [Full Text] [Related]

  • 6. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of cyclooxygenase-2 gene expression on tumor invasiveness in a human renal cell carcinoma cell line.
    Chen Q, Shinohara N, Abe T, Harabayashi T, Nonomura K.
    J Urol; 2004 Dec; 172(6 Pt 1):2153-7. PubMed ID: 15538221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants.
    Fu YG, Sung JJ, Wu KC, Wu HP, Yu J, Chan M, Chan VY, Chan KK, Fan DM, Leung WK.
    Cancer Lett; 2005 Jun 28; 224(2):243-52. PubMed ID: 15914275
    [Abstract] [Full Text] [Related]

  • 11. Effects of introduction of dThdPase cDNA on sensitivity to 5'-deoxy-5-fluorouridine and tumor angiogenesis.
    Kim R, Murakami S, Toge T.
    Int J Oncol; 2003 Apr 28; 22(4):835-41. PubMed ID: 12632076
    [Abstract] [Full Text] [Related]

  • 12. Mn-SOD antisense upregulates in vivo apoptosis of squamous cell carcinoma cells by anticancer drugs and gamma-rays regulating expression of the BCL-2 family proteins, COX-2 and p21.
    Ueta E, Yoneda K, Kimura T, Tatemoto Y, Doi S, Yamamoto T, Osaki T.
    Int J Cancer; 2001 Nov 28; 94(4):545-50. PubMed ID: 11745442
    [Abstract] [Full Text] [Related]

  • 13. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.
    Histopathology; 2004 Dec 02; 45(6):603-11. PubMed ID: 15569051
    [Abstract] [Full Text] [Related]

  • 15. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
    Honjo S, Kase S, Osaki M, Ardyanto TD, Kaibara N, Ito H.
    Int J Oncol; 2005 Feb 02; 26(2):353-60. PubMed ID: 15645119
    [Abstract] [Full Text] [Related]

  • 16. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
    Inoue K, Kawahito Y, Tsubouchi Y, Kohno M, Yoshimura R, Yoshikawa T, Sano H.
    Biochem Biophys Res Commun; 2001 Sep 28; 287(3):727-32. PubMed ID: 11563856
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK, To KF, Go MY, Chan KK, Chan FK, Ng EK, Chung SC, Sung JJ.
    Int J Oncol; 2003 Nov 28; 23(5):1317-22. PubMed ID: 14532971
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides].
    Wang XP, Xie CG, Dong YW, Zhang RL, Wu LY, Wu K.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1501-4. PubMed ID: 14521730
    [Abstract] [Full Text] [Related]

  • 19. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 20. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X.
    J Gastroenterol Hepatol; 2006 Dec 15; 21(12):1814-20. PubMed ID: 17074019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.